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The existing data support Portugal as the western European country with the highest HIV-1 subtype diversity. However, detailed
phylogenetic studies of Portuguese HIV-1 epidemics are still scarce. Thus, our main goal was to analyze the phylodynamics of a
local HIV-1 infection in the Portuguese region of Minho. Molecular epidemiological analysis was applied to data from 289 HIV-
1-infected individuals followed at the reference hospital of the province of Minho, Portugal, at which isolated viruses had been
sequenced between 2000 and 2012. Viruses of the G (29.1%) and B (27.0%) subtypes were the most frequent, followed by recom-
binant forms (17.6%) and the C (14.5%), F1 (7.3%), and A1 (4.2%) subtypes. Multinomial logistic regression revealed that the
odds of being infected with the A1 and F1 subtypes increased over the years compared with those with B, G, or C subtypes or re-
combinant viruses. As expected, polyphyletic patterns suggesting multiple and old introductions of the B and G subtypes were
found. However, transmission clusters of non-B and non-G viruses among native individuals were also found, with the dates of
the most recent common ancestor estimated to be in the early 2000s. Our study supports that the HIV-1 subtype diversity in the
Portuguese region of Minho is high and has been increasing in a manner that is apparently driven by factors other than immi-
gration and international travel. Infections with A1 and F1 viruses in the region of Minho are becoming established and are
mainly found in sexually transmitted clusters, reinforcing the need for more efficacious control measures targeting this infection
route.
Globally, at the end of 2012, 35.3 million people were estimatedto be infected with HIV-1, and AIDS remains one of the
world’s most serious health challenges (1). Phylogenetically,
HIV-1 is divided into four groups: M, O, N, and P. Most HIV-1
infections are globally caused by M group viruses that can be fur-
ther divided into at least nine subtypes, A to D, F to H, J, and K, as
well as different circulating and unique recombinant forms (2).
Although clinical evidence is still limited, and current antiretrovi-
ral regimens appear to have comparable efficacies with all sub-
types, there is presently evidence showing that particular HIV-1
subtypes may have a transmission advantage (3–6), higher repli-
cative efficiency, or altered drug susceptibilities (7–11). The geo-
graphic patterns of the M group subtypes are continuously chang-
ing in response to human population migrations and active
transmission networks, thus inciting constant vigilance. Although
several reports suggest that the prevalences of non-B subtypes are
increasing in western Europe (12–17), the B subtype remains the
most prevalent. Portugal contrasts with the rest of western Eu-
rope in its distribution of HIV-1 subtypes. In addition to the B
subtype, Portugal also has a high prevalence of the G subtype
(18–23). The high prevalences of the B and G subtypes are thought
to have promoted the appearance among intravenous drug users
(IDU) of different types of B/G recombinant strains, namely,
CRF14_BG, which is considered to have emerged in Portugal in
the early 1990s and then spread to Spain and other European
countries (24–26). The association between HIV-1 subtype and
risk-behavior patterns has been complex to define, mainly due to
difficulties in obtaining large numbers of each viral subtype and
transmission route within a homogeneous study population (27).
Portugal has one of the highest HIV-1 prevalence rates in west-
ern Europe and, following a decrease in the last decade of HIV-1
infection in IDU, heterosexual contact is now estimated to be the
most relevant transmission route in Portugal (28). The recon-
struction of viral transmission networks is a relevant tool to mon-
itor disease transmission and the effectiveness of adopted preven-
tive measures, as well as to suggest more adequate control
strategies for specific populations. Several studies have shown that
in addition to a patient interview, phylogenetic analysis of the
genetic sequences from the isolated viruses can provide valuable
insights to help identify events of onward transmission and eval-
uate the spread of the virus (29–31). Nonetheless, limited infor-
mation is available to understand HIV-1 transmission clusters in
Portugal.
The aim of this study was to perform a molecular epidemio-
logic characterization of a cohort of 289 patients followed in the
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reference hospital in Minho province, Portugal. Specifically, we
aimed to identify local transmission networks and possible rela-
tionships with previously described transmission clusters. In line
with previous studies in Portugal, we found a large diversity of
subtypes. In addition, our analysis supports that the transmission
of nonpredominant subtypes among the local population began
more than a decade ago, providing valuable insights into the dy-
namics of infection in this geographic area.
MATERIALS AND METHODS
Study population. From 2000 to 2012, a total of 792 HIV-1 patients were
followed at Hospital de Braga (HB), representing 60.3% of the HIV-1-
infected individuals in the Portuguese region of Minho (28). Two hun-
dred eighty-nine individuals from this cohort were selected for this study,
according to two criteria: (i) availability of a plasma sample or plasma-
derived viral sequence sampled from 2000 to 2012 and (ii) the absence of
previous antiretroviral treatment at the time of sampling. The following
information was collected anonymously from the clinical files of each
individual: presumed transmission route, gender, age, nationality, pre-
sumed country of infection, and date of diagnosis. HB is a university-
affiliated hospital serving as the reference hospital for the 1,093,021 habi-
tants of the northwest Portuguese province of Minho. The prevalence of
HIV-1 infection in the Minho region (0.12%) is lower than the overall
prevalence in Portugal (0.31%) (28). According to transmission mode,
the HB population presented significant differences from the data for the
Portuguese HIV-1-infected individuals, with more IDU and fewer men
who have sex with men (MSM) being infected. Also, in HB, there were
more men and fewer patients40 years old who were infected (see Table
S1 in the supplemental material). The frequencies of individuals reporting
heterosexual transmission are similar in a comparison of HB HIV-1 pa-
tients with the overall country data (see Table S1).
Sequencing of viral samples. Viral RNA was extracted using MagNA
Pure total nucleic acid isolation kits (Roche Applied Science). Reverse
transcriptase PCR (RT-PCR) and DNA sequencing were performed with
the Trugene HIV-1 genotyping system (Siemens Healthcare Diagnostics).
The sequenced regions include part of the coding sequences of Gag (492 to
501), p6 (44 to 53), Pol (60 to 402), p2p7p1p6 (129 to 138), protease (4 to
99), and reverse transcriptase (RT) (1 to 127) (the reported positions are
amino acid positions relative to the protein start in the HXB2 reference
genome, GenBank accession no. K03455.1). The subtyping of the 289
sequences was made using REGA 3.0 (32). The subtyping results were
confirmed using SimPlot and RDP (33, 34). The sequences were uploaded
to GenBank and assigned the accession numbers KM205831 to
KM206119.
Phylogenetic analysis. The 289 HIV-1 sequences obtained in this
study and 88 sequences from the databases, including the M group con-
sensus and a previously defined set (32) of comprehensive subtype refer-
ence sequences with at least two reference sequences from each M group
subtype (A1, A2, B, C, D, F1, F2, G, H, J, and K) and from 26 different
circulating recombinant forms (CRF) (CRF01_AE, CRF02_AG,
CRF03_AB, CRF04_CPX, CRF05_DF, CRF06_CPX, CRF10_CD, CRF11_
CPX, CRF12_BF, CRF13_CPX, CRF14_BG, CRF18_CPX, CRF19_CPX,
CRF20_BG, CRF24_BG, CRF25_CPX, CRF27_CPX, CRF29_BF, CRF31_
BC, CRF35_AD, CRF37_CPX, CRF39_BF, CRF40_BF, CRF42_BF, and
CRF47_BF), were aligned using MUSCLE (35). The phylogenetic analysis
of the 377 sequences was conducted using RAxML 8.0.9 to produce a
maximum likelihood tree using 1,000 bootstrapping replicates (36). The
analysis was repeated with PhyML (37), computing the approximate like-
lihood ratio test (aLRT) support of all tree branches, and by Bayesian
analysis using BEAST (38). The best-fitting nucleotide substitution model
was estimated using jModeltest version 2.1.2 (39) to be the general time
reversible (GTR) model, with a proportion of invariant site (I) and
gamma distribution of rates (G), selected among 88 different models ac-
cording to the Akaike information criterion (AIC), the Bayesian informa-
tion criterion (BIC), and the decision theoretic framework (DT). An even-
tual bias introduced by convergent evolution due to the presence of drug-
resistant mutations was discarded by repeating the analysis after the
removal of codons associated with drug resistance in the standardized list
of mutations for the surveillance of transmitted drug resistance estab-
lished by the World Health Organization (40). The general topology of the
trees and identification of the clustering remained unchanged. The iden-
tification of transmission clusters was based on the maximum likelihood
tree, selecting the clusters from at least three individuals, with a bootstrap
support of95% and an average genetic distance of0.03 substitutions
per site (29, 41). We also used Bayesian inference, and all identified clus-
ters showed a posterior probability equal to 1 (42).
Estimation of evolutionary dates. Estimates of the time of the most
recent common ancestor (MRCA) were performed by simultaneously
inferring population parameters, substitution parameters, and tree topol-
ogy using Bayesian Markov chain Monte Carlo (MCMC) inference, as
implemented in BEAST version 1.8.0 (38). Three independent runs of 260
million replicates were performed under a Bayesian skyline relaxed mo-
lecular clock model, using a general time reversible nucleotide substitu-
tion model, with heterogeneity among the sites modeled with a gamma
distribution. An examination of the MCMC samples with Tracer version
1.6 indicated convergence and adequate mixing of the Markov chains.
After inspection with Tracer, we discarded an appropriate number of
steps from each run as burn-in and combined the resulting MCMC tree
samples for a subsequent estimation of posteriors using TreeAnnotator
version 1.8.0. We summarized the MCMC samples using the maximum
clade credibility tree, with the branch length depicted in years.
Statistical analysis. To identify the main predictors of HIV-1 subtype
group distribution, a multinomial logistic regression model was per-
formed. Using this procedure, we assessed the association between the
date of diagnosis and HIV-1 subtype group, controlling for other relevant
variables. The HIV-1 subtypes with low numbers of cases were pooled,
TABLE 1 Demographics of the study population
Variablea No. %
Gender
Male 222 76.8
Female 67 23.2
Age at diagnosis (yr)
20 17 5.9
21–40 190 65.7
41–50 41 14.2
50 41 14.2
Patient nationality
Portuguese 260 90.0
Other 29 10.0
Ethnicity
White 274 94.8
Black 15 5.2
Presumed country of infection
Portugal 280 96.9
Other 9 3.1
Route of transmission
Heterosexual contact 161 55.7
MSM 26 9.0
IDU 99 34.2
Other 3 1.1
Total 289 100
a IDU, intravenous drug users; MSM, men who have sex with men.
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FIG 1 HIV-1 subtype diversity and temporal distribution of the date of diagnosis in the cohort of 289 HIV-1-infected individuals from the province of Minho,
Portugal.
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resulting in 5 groups that were used for statistical analysis: G (n 84), B
(n 75), C (n 42), other subtypes (A1, n 12; F1, n 21; total, n
33), and recombinants (n 42). The least represented subtypes, J (n 1)
and D (n 3), had no influence on the results and were excluded from the
analysis. The independent variables analyzed were date of diagnosis, age,
gender, and transmission route. The IBM SPSS package (version 19) was
used to conduct all statistical analysis, and the results were considered to
be significant at a P value of0.05.
Ethics. The project was approved by the ethics committee of the HB.
Written consent was obtained from all patients enrolled in the study. The
clinical data were codified to ensure the confidentiality of the patients.
RESULTS
High HIV-1 subtype diversity. Among the 289 individuals who
met the inclusion criteria, 76.8% were male, and the average age at
diagnosis in the study population was 44.5 years (range, 18 to 87
years) (Table 1). The most frequently reported route of infection
was heterosexual contact (n  161 [55.7%]), followed by IDU
(n 99 [34.2%]) and MSM (n 26 [9.0%]) (Table 1). In accor-
dance with the population of Minho, the study population was
highly homogeneous, with90% of the individuals being Portu-
guese, of white ethnicity, and presumed to have been infected in
Portugal. The most frequent subtypes found were G (n  85
[29.4%]), B (n 75 [26%]), and C (n 42 [14.5%]), followed by
the F1 (n  22 [7.6%]) and A1 (n  12 [4.2%]) subtypes. Only
1.4% of the studied individuals were infected with other “pure”
subtypes (D, n 3; J, n 1). The most frequently found CRF was
CRF14_BG (n  15 [5.2%]), followed by CRF02_AG (n  4
[1.4%]). Individuals infected with unique recombinant forms
(URF) constituted 9.0% of the population (Fig. 1A).
Increasing incidence of infection with A1 and F1HIV-1 sub-
types. The dates of HIV-1 diagnosis in the study population
spanned the period 1987 through 2012. We investigated the pro-
portion of infections diagnosed each year with different subtypes.
The less frequent subtypes were pooled to allow for statistical anal-
ysis (Fig. 1B), and a significant multinomial logistic regression
model was obtained (2(df  20)  77.3; P  0.001; pseudo-
R2Nagelkerke, 0.245). The model (Table 2) shows that the chance of
being infected with the A1 or F1 subtype increased during the
period of time studied compared to that with the other subtypes
(odds ratio [OR], 0.852 andP 0.05 for recombinant viruses; OR,
0.824 and P 0.01 for G subtypes; OR, 0.781 and P 0.001 for B
subtypes; and OR, 0.862 and P  0.05 for C subtypes). Overall,
these data support the hypothesis that infection with A1 and F1
subtypes began to appear recently in Minho province but are be-
coming established.
Evidence for local transmission clusters. The phylogenetic
analysis of the viral sequences allowed the identification of 17
transmission clusters (Fig. 2). This analysis was performed using a
maximum likelihood tree and confirmed by Bayesian inference
(see Table S2 in the supplemental material). Of all the sequences,
TABLE 2 Multinomial logistic regression model relating HIV-1 subtypes with date of diagnosis, age, gender, and presumed transmission mode
Subtype comparison Variable Be SE Walda ORb
95% CIc
LB UB
Recombinants vs A1/F1 Days (or yr) since
date of diagnosis
0.0004 0.000 6.278* 1.000 (0.852) 0.999 1.000
Age 0.006 0.019 0.091 0.994 0.959 1.031
Male 0.298 0.638 0.218 1.347 0.386 4.699
Heterosexual 0.808 0.735 1.207 0.446 0.106 1.884
IDUd 0.346 0.820 0.178 0.708 0.142 3.533
G vs A1/F1 Days (or yr) since
date of diagnosis
0.001 0.000 10.774** 0.999 (0.824) 0.999 1.000
Age 0.016 0.016 1.100 1.016 0.986 1.048
Male 0.847 0.476 3.167 0.429 0.169 1.090
Heterosexual 1.450 1.161 1.559 4.264 0.438 41.537
IDU 2.012 1.214 2.747 7.475 0.693 80.672
B vs A1/F1 Days (or yr) since
date of diagnosis
0.001 0.000 17.319*** 0.999 (0.781) 0.999 1.000
Age 0.016 0.017 0.932 0.984 0.952 1.017
Male 0.473 0.512 0.856 0.623 0.229 1.698
Heterosexual 1.234 0.663 3.459 0.291 0.079 1.069
IDU 1.593 0.771 4.269* 0.203 0.045 0.921
C vs A1/F1 Days (or yr) since
date of diagnosis
0.000 0.000 5.154* 1.000 (0.862) 0.999 1.000
Age 0.017 0.019 0.815 1.017 0.980 1.056
Male 0.646 0.579 1.242 0.524 0.168 1.632
Heterosexual 0.267 0.949 0.079 0.766 0.119 4.919
IDU 1.216 0.996 1.491 3.374 0.479 23.754
a *, P 0.05; **, P 0.01; ***, P 0.001.
b OR, odds ratio.
c 95% CI, 95% confidence interval; LB, lower bound; UB, upper bound.
d IDU, intravenous drug users.
e B, regression coefficient.
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39.4% grouped in the 17 transmission clusters. In terms of HIV-1
subtype distribution, 7 clusters included subtype B viruses, three
included subtype F1, two included subtype G, two included sub-
type C, one included subtype A1, one included CRF14_BG, and
one included DB URF (Table 3). The distribution of the clustered
sequences per subtype showed that 95.5% of all F1 sequences (21
out of 22) were incorporated in clusters. Respectively, 66.7%,
80.9%, and 80% of all A1, C, and CRF14_BG sequences were
found in clusters. In contrast, the B and G subtype clusters include
only 35.9% and 11.8% of the B and G subtype sequences, respec-
tively. The mean number of individuals per cluster was 6.9.
Among the clusters with a number of individuals that was above
the mean, the largest cluster was 11C. It was composed almost
entirely of IDU (27 out of 31 individuals), and 4 of these individ-
uals reported sharing injection material. The second largest cluster
was 17BG, and it was also composed mainly of IDU (11 out of 12
individuals), with the non-IDU individual in the cluster reporting
sexual contact with one of the other members of the cluster. For all
F1 clusters (13F1, 14F1, and 15F1), the transmission mode was
predominantly sexual (Table 3). In the 13F1 cluster, 1 patient out
of 10 was of Brazilian nationality. Furthermore, the phylogenetic
analysis shows that the viral sequences from the 13F1 and 14F1
clusters have common ancestors with reference sequences col-
lected in Brazil (GenBank accession no. AY173957.1, EU735538.1,
and EU735540.1). Additionally, BLAST analysis identified 5 se-
quences highly related to the 14F1 cluster (GenBank accession no.
GQ251099, GQ251280, GQ251075, GQ251072, and GQ251122;
Fig. 3) viruses that were isolated in Italy and phylogenetically
linked to those in Brazil (43). Cluster 16A1 was a sexually trans-
mitted cluster (5 heterosexual and 3 MSM).
Established local transmission of non-B/G HIV-1 subtypes.
In order to estimate the evolutionary dates of the reported trans-
mission clusters, we performed a Bayesian MCMC analysis. All
independent runs converged to almost identical values for all pa-
FIG 2 Phylogenetic relationships among the HIV-1 sequences isolated from 289 infected individuals from Minho province, Portugal. Maximum likelihood
(ML) phylogenetic analysis was performed using 289 partial HIV-1 sequences obtained in this study and 89 subtype reference sequences (colored in blue) and
rooted using the M-group consensus sequence. The branch lengths are expressed as the number of nucleotide substitutions per site. The transmission clusters
(colored in pink) were supported by an ML bootstrap support of95% based on 1,000 replicates, an average genetic distance of0.03 substitutions per site, and
a Bayesian posterior probability equal to 1.
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rameters (data not shown). The mean substitution rate was 2.16
103 (95% highest posterior density [HPD] interval, 1.85 103
to 2.49  103) substitutions per site per year. The date of the
most recent common ancestor (MRCA) was determined for all the
clusters and ranged from 1994 to 2008 (Table 3). There were no
marked differences in the MRCA dates among the different sub-
types. Among the clusters of nonprevalent HIV-1, the 11C, 15F1,
16A1, and 17BG subtypes were the ones with older MRCA dates,
ranging from 1994 to 1999. These clusters are composed of viruses
from Portuguese individuals presumed to be infected in Portugal
(Table 3). These results support the existence of clusters of non-
prevalent subtypes that started transmitting among the local pop-
ulation more than a decade ago. To gain insights into the activities
of the clusters over the years, the date of HIV-1 diagnosis for all
cluster-included individuals was analyzed. For the majority of the
clusters, the results are suggestive of continuous onward transmis-
sion (Table 3). A possible exception is cluster 17BG, since it
showed an earlier mean date of diagnosis (2002) and since in the 6
years from 2006 to 2012, no viruses belonging to this cluster were
found in the study population, thus suggesting a decrease in trans-
mission.
DISCUSSION
Since its origin in Africa approximately 100 years ago, HIV-1 has
continuously been undergoing genetic diversification that is en-
hanced by the massive globalization of the human population
(21). Despite the perception that current antiretroviral regimens
have comparable efficacies across existing diverse HIV-1 subtypes,
there is evidence showing that some HIV-1 subtypes may have a
transmission advantage, higher replicative efficiency, or even al-
tered drug susceptibility (7–11), raising awareness on the rele-
vance of investigating HIV-1 diversity. Furthermore, for the effec-
tive targeting of preventive measures, it is very relevant to perform
persistent monitoring of the HIV-1 pandemic using phylogenetic
and epidemiological data analyses as tools in the reconstruction of
viral transmission networks (27–29).
Existing data show that Portugal contrasts with the rest of west-
ern Europe in its distribution of HIV-1 subtypes (18, 21). It is
important to gain a further understanding on the causes underly-
ing this difference, also in light of the evidence supporting a recent
increase in infections with non-B HIV-1 subtypes in several west-
ern European countries (15–17, 44). In this study, we analyzed 289
HIV-1-infected individuals from Minho province, Portugal. Col-
lectively, the results obtained are consistent with previous studies
in Portugal showing a high prevalence of non-B subtypes (73.0%),
mainly viruses of the G subtype (29.4%), followed by those of the
C (14.5%) subtype. In our study population, the heterogeneity of
HIV-1 subtypes is attributable to Portuguese-born individuals
presumed to be infected in the region, with only 3.8% of the cases
occurring in immigrants or individuals from Portugal presumed
to be infected elsewhere. Contrarily, the rising prevalence of
non-B HIV-1 subtypes in western Europe has been attributed to
the growing number of immigrants from sub-Saharan Africa and
South America, where these variants are prevalent. As an example,
27% of the HIV-1 cases diagnosed in 2007 in Spain were of non-B
subtypes, and 90% of these cases were African and South Ameri-
can immigrants (45). A phylogenetic analysis of our study popu-
lation indicates high interindividual genetic distances for the most
prevalent subtypes, B and G, suggesting old and multiple intro-
ductions of viruses of these subtypes in the region. This observa-
tion is in accordance with the predominance of the B subtype in
western Europe, having probably been introduced on several oc-
casions in the late 1970s and early 1980s (46). As for the G sub-
types, it is possible that the intense human migrations between
Portugal and its former African colonies in the 1970s and 1980s,
due mostly to the independence wars (47), contributed to its early
introduction in Portugal. These intense human migrations may
have also contributed to the early introduction of other HIV-1
subtypes, namely in the case of the migration connection with
Angola, where there is a large HIV-1 genetic diversity (48). The
distribution of clustered sequences per subtype showed that the
vast majority of the F1, C, A1, and CRF14_BG sequences were
incorporated in clusters. Contrarily, the B and G subtype clusters
TABLE 3 Characterization of the 17 HIV-1 transmission clusters identified in the study population of the Portuguese region of Minho
Cluster
name
No. of
individuals HIV-1 subtype Yr of diagnosis (mean, range) Route of transmission (n)a
Time of MRCA
Yr 95% HPD
01DB 3 DB URF 2009, 2006–2012 IDU (4), heterosexual (1) 2002 1998.2–2006.1
02B 3 B 2006, 2003–2008 IDU (2), heterosexual (1) 1999 1994.2–2003.3
03B 5 B 2003, 2000–2009 Heterosexual (2), MSM (1) 2004 2001.9–2006.5
04B 3 B 2007, 2006–2009 Heterosexual (4) 2004 2000.7–2006.9
05B 3 B 2006, 2003–2008 MSM (3), heterosexual (2) 2003 2000.0–2005.6
06B 3 B 2008, 2005–2010 Heterosexual (3) 2002 1998.4–2004.8
07B 3 B 2009, 2008–2010 Heterosexual (3) 2004 2000.0–2006.9
08B 5 B 2007, 2000–2010 Heterosexual (2), MSM (1) 2002 1998.1–2004.4
09G 7 G 2006, 1999–2009 Heterosexual (5), IDU (2) 2000 1997.1–2003.2
10G 3 G 2010, 2008–2011 Heterosexual (2), IDU (1) 2008 2004.8–2010.4
11C 31 C 2004, 1999–2011 IDU (27), heterosexual (4) 1994 1990.4–1998.1
12C 3 C 2006, 2001–2009 Heterosexual (3) 2005 2001.6–2007.6
13F1 10 F1 2006, 2000–2011 Heterosexual (7), IDU (3) 2000 1993.2–2003.5
14F1 7 F1 2009, 2007–2011 Heterosexual (6), IDU (1) 2005 2002.7–2007.2
15F1 4 F1 2010, 2009–2010 Heterosexual (4) 1994 1987.5–2001.6
16A1 8 A1 2009, 2006–2011 Heterosexual (5), MSM (3) 1999 1994.0–2003.3
17BG 12 CRF14_BG 2002, 2000–2006 IDU (10), heterosexual (2) 1999 1994.5–2002.8
a IDU, intravenous drug users; MSM, men who have sex with men.
b MRCA, most recent common ancestor; HPD, high posterior density.
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include only 35.9% and 11.8% of the respective subtype se-
quences, likely due to the long-time circulation of B and G sub-
types among the studied population. Interestingly, clusters of
non-B and non-G subtypes were also found, namely those of the
C, F1, A1, and CRF14_BG viruses, with MRCA dates in the late
1990s, even when considering only Portuguese-born individuals
presumed to be infected in the region. This supports the hypoth-
esis that these HIV-1 subtypes were introduced in Minho more
than one decade ago. The two largest transmission clusters, 11C
and 17BG, are in a large majority (87%) composed of IDU,
reflecting the compartmentalization and closed character of the
transmission among individuals from this risk group. The analysis
of the date of diagnosis of the individuals in these clusters suggests
that its transmission might be decreasing, namely in the case of
17BG, since in the 6 years ranging from 2006 to 2012, no HIV-1
infection with viruses from this cluster were found in the study
FIG 3 Phylogenetic relationships between the 13F1 and 14F1 transmission cluster sequences and public sequences available in the databases. Maximum
likelihood (ML) phylogenetic analysis was performed using 13F1 and 14F1 sequences (pink), 4 subtype references (blue), and the 50 most similar sequences
obtained in the BLAST query of all publically available sequences. Highlighted in purple are the public sequences that are included in cluster 14F1. The tree was
rooted using the M-group consensus.
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population. In the last decade, other local epidemics with
CRF14_BG have been described among IDU in Spain and Portu-
gal (20, 22). Our results are in line with the data showing a de-
crease in the prevalence of HIV-1 among IDU in Portugal (28),
consequently reducing the transmission of BG recombinant vi-
ruses. Importantly, our data support an increased incidence of
infection with the F1 and A1 subtypes in the study population. The
occurrence of onward transmission events of F1 and A1 HIV-1
subtypes in our study population was strongly linked to sexual
transmission. We identified three F1 clusters, mainly formed by
individuals who report heterosexual contact as the presumed viral
transmission route. The phylogenetic analysis shows that the viral
sequences from clusters 13F1 and 14F1 have common ancestors
with reference sequences collected in Brazil. The analysis of the
public databases allowed the identification of 5 sequences isolated
in Italy that belong to the 14F1 cluster, thus suggesting a large
geographic range of this transmission network, contrary to what
was found in all the other clusters. In common with the 13F1 and
14F1 clusters, the previously described Italian cluster was also
phylogenetically linked to Brazil (43), suggesting this country as
the origin of subtype F1 viruses in southern Europe. We also iden-
tified one sexually transmitted A1 subtype cluster (16A1) that was
epidemiologically linked to Mozambique, since a viral sequence
isolated from one Mozambican presumed to be infected prior to
immigrating to Portugal had a common ancestor with the cluster.
Overall, our study of the local HIV-1 epidemic in the Portu-
guese region of Minho supports that it contrasts with other re-
gions of western Europe in its high HIV-1 diversity. This diversity
is increasing due to transmission among native individuals and
not in a manner driven by immigration or international travel.
Our molecular and epidemiologic analyses highlight the onward
transmission of the F1 and A1 subtype viruses via sexual transmis-
sion routes, supporting the need for continuous monitoring and
strengthening of preventive strategies targeted at this transmission
mode.
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